Similarly, the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) [47] and the Study of Heart and Kidney Protection with Empagliflozin (EMPA-KIDNEY) [48] trials expanded inclusion beyond diabetes mellitus, showing that dapagliflozin and empagliflozin significantly reduced the risk of kidney outcomes, with consistent benefits across a wide range of eGFR and albuminuria
Temporary Acne Flares: Mechanism and Management A subset of GLP-1 patients experience acne flares during the first 48 weeks of treatment, often coinciding with rapid metabolic shifts and initial weight loss
If you continue to feel fatigued despite adequate B12 levels, our experienced healthcare providers are here to help you explore other possible causes and find the right treatment plan for you
Clinical Trials Show Orforglipron is Effective
ej., aquellos despus de un accidente cerebrovascular o revascularizacin, o con evidencia de estenosis arterial significativa en muchos lechos [carotdeo, coronario o perifrico])